Schedule 13G ownership disclosure
Inhibrx Biosciences Inc
Security class unavailable · CUSIP: 45720N103
Event date: 2024-05-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-259034
- Form type
- SC 13G
- Filer
- Inhibrx Biosciences, Inc.
- CIK
- CIK 2007919
- Filed
- Nov 14, 2024
- Reporting period
- May 30, 2024
- Description
- Schedule 13G beneficial ownership